Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02103881

Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital

A Double Blinded Randomized Trial of Ketamine Versus Haloperidol for Severe Prehospital Agitation

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hennepin Healthcare Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study is being done to find out if one of two drugs, ketamine or haloperidol, is better for treating agitation. Agitation is a state of extreme emotional disturbance where patients can become physically aggressive or violent, endangering themselves and those who are caring for them. Often chemical substances or severe mental illness is involved in this level of agitation. Specifically, the investigators are interested in studying agitation that is treated in the prehospital setting by paramedics. This study's hypothesis is that ketamine is superior to haloperidol for treatment of agitation in the prehospital environment.

Conditions

Interventions

TypeNameDescription
DRUGKetamine500 mg of intramuscular ketamine for severe pre-hospital agitation
DRUGHaloperidolHaloperidol 10 mg intramuscular for severe prehospital agitation.

Timeline

Start date
2014-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2014-04-04
Last updated
2017-07-24

Source: ClinicalTrials.gov record NCT02103881. Inclusion in this directory is not an endorsement.